 | Kristin Ardlie, Director, Biological Samples Program, Broad Institute |
 | Lori Ball , Senior Vice President, Global Operations, Biostorage Technologies |
 | Karina Bienfait, Clinical Pharmacogenomics Operations Lead, Merck & Company
|
 | John Bloom, President, Bloom Consulting Services LLC |
 | Andrew Brooks,Associate Professor, Environmental Medicine & Genetics, Rutgers Environmental Health Sciences |
 | Lynn Bry, Director, Biorepository, Partners Healthcare |
 | L. Scott Clark, Chief Scientific Officer, Gentris
|
 | Shoibal Datta, Head of Translational Informatics Group in R&D IT, Biogen Idec |
 | Sascha Ellers, Senior Manager, Development Sciences, Genentech Inc |
 | Stephen Furlong, Safety Science Lead, Astrazeneca |
 | Lisa Gilbert, Director of Global Marketing, Biostorage Technologies Inc |
 | Robert James Gordon, Global Technical Director - Cryoscience Unit, Taylor-Wharton
|
 | Eric Halvorsen, Director, Business and Technology Development, TIDO, Children's Hospital Boston |
 | Anne Janssen, Senior Principal Scientist, Pfizer Inc |
 | Dale Larson, Director, Biomedical Engineering, Draper Laboratory |
 | Liis Leitsalu, Specialist, Estonian Genome Center, University of Tartu |
 | Ashi Malekafzali, Manager, Sample Collaborations, Genentech Inc |
 | Cathy Michael, Global Head, Sample Management Operations, Biostorage Technologies |
 | Lisa Miranda, President, Biobusiness Consulting Inc |
 | Helen Moore, Biospecimen Research Network Prgm Mgr, Office of the Director, National Cancer Institute |
 | Suzanne O'Shea, Legal Counsel, Baker & Daniels LLP
|
 | Marie-Claire Peakman, Executive Director, Research Centers of Emphasis, Pfizer Inc |
 | Michael Roehrl, Assistant Professor of Pathology and Laboratory Medicine, Boston University |
 | Steve Sweeney, Director ofClinical Operations, Infinity Pharmaceuticals
|
 | Cheryl Tow-Keogh, Scientist, Pfizer |
 | Renu Vora, Senior Associate Scientist, Centocor |
 | Amelia Wall Warner, Head Clinical Pharmacogenomics, Merck & Company |
 | Monte Wetzel, Head of Licensing, Roche Molecular Systems |
 | Kenneth Wilke, Clinical Pharmacogenomics and Specimen Management, Merck |
 | Wendy Wolf Director, Biorepository, Children's Hospital Boston |
| | |